Codon 72 polymorphism of TP53 gene is a novel prognostic marker for therapy in multiple myeloma.

Authors: Hattori, Y  Ikeda, Y  Suzuki, Y  Ichikawa, D  Matsushita, M 
Citation: Hattori Y, etal., Br J Haematol. 2014 Jun;165(5):728-31. doi: 10.1111/bjh.12784. Epub 2014 Feb 24.
Pubmed: (View Article at PubMed) PMID:24611901
DOI: Full-text: DOI:10.1111/bjh.12784



Disease Annotations
Objects Annotated

Additional Information

CRRD Object Information
CRRD ID: 11073716
Created: 2016-05-04
Species: All species
Last Modified: 2016-05-04
Status: ACTIVE


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.